Many tumor cell lines display intrinsic resistance to TRAIL even though they express the necessary cell surface receptors confirming that, during evolution of tumors in vivo, selection occurs for malignant clones capable of withstanding immune attack. This evidence concerns the gene TNFSF10 and neoplasm.